10th Edition of
World Congress on Infectious Diseases & One Health
October 05-07, 2026 | Tokyo, Japan
Antiparasitic Agents play a crucial role in combating various parasitic infections, showcasing their significance within the broader context of antimicrobials. These agents specifically target and eliminate parasitic organisms, preventing their growth and reproduction. Commonly used antiparasitic drugs include anthelmintics for helminthic infections and antiprotozoals for protozoan infections. One notable class of antiparasitic agents is the benzimidazoles, which disrupt the microtubule structure of parasitic cells, inhibiting their ability to divide. Additionally, antimalarial drugs, such as chloroquine and artemisinin derivatives, are vital components of antiparasitic strategies, effectively addressing the global burden of malaria. Combining both synthetic and natural compounds, antiparasitic agents demonstrate a multifaceted approach to eradicating parasitic infections. Their efficacy is underscored by ongoing research and development efforts to enhance treatment outcomes and minimize adverse effects, contributing significantly to the field of antimicrobials.
Title : Molecular crosstalk between the host and pathogen in Streptococcus pyogenes virulence
Francis J Castellino, University of Notre Dame, United States
Title : Phenotypic characterisation of non tuberculous mycobacterium species isolated from clinical specimens
Anant Marathe, Parul Institute of Medical Sciences and Research, Parul University, India
Title : Praziquantel for the treatment of preschool-aged children with schistosomiasis: Results of an RCT
Susannah Colt, Warren Alpert Medical School of Brown University, United States
Title : Carbapenemase-producing multidrug resistance of gram negative bacilli causing bacteremia at the general hospital of Mexico during the Covid-19 pandemic
Silvia Giono, Instituto Politecnico Nacional, Mexico
Title : The largest histamine poisoning outbreak in Brazil: An experience report from a one health perspective in Fernando de Noronha
Camila Ferro, Fundacao Oswaldo Cruz (Fiocruz), Brazil
Title : Combating antimicrobial resistance in sub-Saharan Africa: Advancing one health strategies for sustainable infectious disease control
Ugorji Miracle Enyinnaya, Greatlink Pharmaceutical, Nigeria